Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-grade Serous Ovarian Carcinoma.
Ricciardi E, Baert T, Ataseven B, Heitz F, Prader S, Bommert M, Schneider S, du Bois A, Harter P. Ricciardi E, et al. Among authors: baert t. Geburtshilfe Frauenheilkd. 2018 Oct;78(10):972-976. doi: 10.1055/a-0717-5411. Epub 2018 Oct 19. Geburtshilfe Frauenheilkd. 2018. PMID: 30364401 Free PMC article.
How to manage lymph nodes in ovarian cancer.
Harter P, Heitz F, Ataseven B, Schneider S, Baert T, Prader S, du Bois A. Harter P, et al. Among authors: baert t. Cancer. 2019 Dec 15;125 Suppl 24:4573-4577. doi: 10.1002/cncr.32514. Cancer. 2019. PMID: 31967675 Free article. Review.
Low-grade Serous Tumors: Are We Making Progress?
Pauly N, Ehmann S, Ricciardi E, Ataseven B, Bommert M, Heitz F, Prader S, Schneider S, du Bois A, Harter P, Baert T. Pauly N, et al. Among authors: baert t. Curr Oncol Rep. 2020 Jan 27;22(1):8. doi: 10.1007/s11912-020-0872-5. Curr Oncol Rep. 2020. PMID: 31989304 Review.
Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
Ataseven B, Tripon D, Rhiem K, Harter P, Schneider S, Heitz F, Baert T, Traut A, Pauly N, Ehmann S, Plett H, Schmutzler RK, du Bois A. Ataseven B, et al. Among authors: baert t. Geburtshilfe Frauenheilkd. 2020 Sep;80(9):932-940. doi: 10.1055/a-1222-0042. Epub 2020 Sep 2. Geburtshilfe Frauenheilkd. 2020. PMID: 32905297 Free PMC article.
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
Plett H, Filippova OT, Garbi A, Kommoss S, Rosendahl M, Langstraat C, Phadnis S, Muallem MZ, Baert T, Chi DS, Aletti GD, Taran FA, Ramspott JP, Zivanovic O, du Bois A, Sonoda Y, Gardner G, Traut A, Roche KL, Harter P. Plett H, et al. Among authors: baert t. Gynecol Oncol. 2020 Nov;159(2):434-441. doi: 10.1016/j.ygyno.2020.08.028. Epub 2020 Sep 9. Gynecol Oncol. 2020. PMID: 32919778 Free PMC article.
Response evaluation after neoadjuvant therapy: evaluation of chemotherapy response score and serological and/or radiological assessment of response in ovarian cancer patients.
Ramspott JP, Baert T, MacKintosh ML, Traut A, Ataseven B, Bommert M, Heitz F, Plett H, Schneider S, Waltering KU, Heikaus S, Harter P, du Bois A. Ramspott JP, et al. Among authors: baert t. Arch Gynecol Obstet. 2021 Oct;304(4):1021-1032. doi: 10.1007/s00404-021-06020-y. Epub 2021 Mar 4. Arch Gynecol Obstet. 2021. PMID: 33661392
Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.
Pauly N, Baert T, Schmutzler R, du Bois A, Schneider S, Rhiem K, Schömig-Markiefka B, Siemanowski J, Heikaus S, Traut A, Heitz F, Prader S, Ehmann S, Harter P, Ataseven B. Pauly N, et al. Among authors: baert t. Arch Gynecol Obstet. 2021 Oct;304(4):975-984. doi: 10.1007/s00404-021-06006-w. Epub 2021 Mar 12. Arch Gynecol Obstet. 2021. PMID: 33710393
53 results